These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10951931)

  • 21. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
    Lethagen S
    Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates.
    von Auer Ch; Oldenburg J; von Depka M; Escuriola-Ettinghausen C; Kurnik K; Lenk H; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1051():498-505. PubMed ID: 16126990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmopressin for the treatment of haemophilia.
    Castaman G
    Haemophilia; 2008 Jan; 14 Suppl 1():15-20. PubMed ID: 18173690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New assays for monitoring haemophilia treatment.
    Shima M; Matsumoto T; Ogiwara K
    Haemophilia; 2008 Jul; 14 Suppl 3():83-92. PubMed ID: 18510527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patients.
    Auerswald G; Spranger T; Brackmann HH
    Haematologica; 2003 Jun; 88(6):EREP05. PubMed ID: 12826531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
    Johansen RF; Sørensen B; Ingerslev J
    Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia a and inhibitors.
    d'Oiron R; Volot F; Reynaud J; Peerlinck K; Goudemand J; Guérois C; Rothschild C; Chambost H; Borel-Derlon A; Roussel-Robert V; Marquès-Verdier A; Lienhart A; Berthier AM; Moreau P; Lambert T;
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S3-9. PubMed ID: 16427382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
    Gringeri A; Monzini M; Tagariello G; Scaraggi FA; Mannucci PM;
    Haemophilia; 2006 Mar; 12(2):128-32. PubMed ID: 16476086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of inhibitors in mild/moderate haemophilia A.
    Peerlinck K; Jacquemin M
    Haemophilia; 2006 Dec; 12 Suppl 6():43-7. PubMed ID: 17123393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation factors with improved properties for hemophilia gene therapy.
    Pipe SW
    Semin Thromb Hemost; 2004 Apr; 30(2):227-37. PubMed ID: 15118934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical gene transfer studies for hemophilia A.
    Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):249-56. PubMed ID: 15118936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
    van Helden PM; van den Berg HM; Gouw SC; Kaijen PH; Zuurveld MG; Mauser-Bunschoten EP; Aalberse RC; Vidarsson G; Voorberg J
    Br J Haematol; 2008 Aug; 142(4):644-52. PubMed ID: 18510679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FVIII gene delivery by muscle electroporation corrects murine hemophilia A.
    Long YC; Jaichandran S; Ho LP; Tien SL; Tan SY; Kon OL
    J Gene Med; 2005 Apr; 7(4):494-505. PubMed ID: 15521095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].
    Prencipe MA; D'Errico M; Di Giorgio G; Gatta G; Gesuete A; Nobile M; Stallone C
    G Ital Nefrol; 2002; 19(2):204-8. PubMed ID: 12195420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemophilia in urological patients.
    Gowland HW
    Br J Urol; 1970 Dec; 42(6):741-2. PubMed ID: 5491934
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical features and outcome of acquired haemophilia A. Interim analysis of the Düsseldorf study.
    Gheisari R; Bomke B; Hoffmann T; Scharf RE
    Hamostaseologie; 2010 Aug; 30(3):156-61. PubMed ID: 20680232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A standardized treatment regimen for patients with severe haemophilia A undergoing orthopaedic or trauma surgery: a single centre experience.
    Hart C; Heindl B; Spannagl M; Lison S
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):396-402. PubMed ID: 25699605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome after diagnosis of hemophilia A in dogs.
    Aslanian ME; Sharp CR; Rozanski EA; de Laforcade AM; Rishniw M; Brooks MB
    J Am Vet Med Assoc; 2014 Sep; 245(6):677-83. PubMed ID: 25181272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRP1/CD91 is up-regulated in monocytes from patients with haemophilia A: a single-centre analysis.
    Franchini M; Urbani S; Amadei B; Rivolta GF; Di Perna C; Riccardi F; Frattini F; Crestani S; Bonfanti C; Formentini A; Quintavalla R; Tagliaferri A
    Haemophilia; 2013 May; 19(3):e126-32. PubMed ID: 23387825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.